These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17483308)

  • 1. Paradoxes of the EphB4 receptor in cancer.
    Noren NK; Pasquale EB
    Cancer Res; 2007 May; 67(9):3994-7. PubMed ID: 17483308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast.
    Berclaz G; Flütsch B; Altermatt HJ; Rohrbach V; Djonov V; Ziemiecki A; Dreher E; Andres AC
    Oncol Rep; 2002; 9(5):985-9. PubMed ID: 12168060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
    Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
    Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis.
    Berman-Golan D; Granot-Attas S; Elson A
    Cancer Metastasis Rev; 2008 Jun; 27(2):193-203. PubMed ID: 18231724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
    Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
    Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
    Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eph-ephrin signalling in adult tissues and cancer.
    Merlos-Suárez A; Batlle E
    Curr Opin Cell Biol; 2008 Apr; 20(2):194-200. PubMed ID: 18353626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
    Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
    J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging targeted therapies for breast cancer.
    Arnedos M; Seidman AD
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):321-40. PubMed ID: 17512452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the death machinery in mammary epithelial cells: Implications for breast cancer from transgenic and tissue culture experiments.
    Jäger R
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):231-40. PubMed ID: 17604639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.